These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31070287)

  • 1. Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
    Jacobi C; Gahleitner C; Bier H; Knopf A
    Head Neck; 2019 Sep; 41(9):3073-3079. PubMed ID: 31070287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
    Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
    JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of interventions for carotid blowout syndrome in patients with head and neck cancer.
    Liang NL; Guedes BD; Duvvuri U; Singh MJ; Chaer RA; Makaroun MS; Sachdev U
    J Vasc Surg; 2016 Jun; 63(6):1525-30. PubMed ID: 26926937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complication of head and neck cancer: Carotid blowout syndrome.
    Jonas K; Meers A; Gao M
    Am J Emerg Med; 2024 Mar; 77():231.e5-231.e6. PubMed ID: 38290919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of survival following carotid blowout syndrome.
    Silverman DA; Parikh AS; Liu K; Zhan KY; Nimjee SM; Powers CJ; Youssef P; Rocco JW; VanKoevering KK; Kang SY; Old MO; Seim NB
    Oral Oncol; 2022 Feb; 125():105723. PubMed ID: 35063883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum albumin is an important prognostic factor for carotid blowout syndrome.
    Lu HJ; Chen KW; Chen MH; Chu PY; Tai SK; Tzeng CH; Chang PM; Yang MH
    Jpn J Clin Oncol; 2013 May; 43(5):532-9. PubMed ID: 23532187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
    Mroz EA; Patel KB; Rocco JW
    Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid Blowout Syndrome in Head and Neck Cancer Patients: Management of Patients At Risk for CBS.
    Slijepcevic AA; Roh J; Pipkorn P; Lipsey K; Bradley JP
    Laryngoscope; 2023 Mar; 133(3):576-587. PubMed ID: 35575599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular management of carotid blowout syndrome in patients with head and neck cancers.
    Roh JL; Suh DC; Kim MR; Lee JH; Choi JW; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2008 Sep; 44(9):844-50. PubMed ID: 18218333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
    Patil VM; Noronha V; Joshi A; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; Mahimkar M; Juvekar S; Arya S; Mahajan A; Agarwal A; Purandare N; Rangarajan V; Balaji A; Chaudhari SV; Banavali S; Kannan S; Bhattacharjee A; D'Cruz AK; Chaturvedi P; Pai PS; Chaukar D; Pantvaidya G; Nair D; Nair S; Deshmukh A; Thiagarajan S; Mathrudev V; Manjrekar A; Dhumal S; Maske K; Bhelekar AS; Nawale K; Chandrasekharan A; Pande N; Goel A; Talreja V; Simha V; Srinivas S; Swami R; Vallathol DH; Dsouza H; Shrirangwar S; Turkar S; Abraham G; Thanky AH; Patel U; Pandey MK; Prabhash K
    Cancer; 2019 Sep; 125(18):3184-3197. PubMed ID: 31150120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
    Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
    Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
    Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma.
    Knopf A; Teutsch S; Bier H
    BMC Health Serv Res; 2021 Jan; 21(1):45. PubMed ID: 33419421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal carotid blowout syndrome after BNCT for head and neck cancers.
    Aihara T; Hiratsuka J; Ishikawa H; Kumada H; Ohnishi K; Kamitani N; Suzuki M; Sakurai H; Harada T
    Appl Radiat Isot; 2015 Dec; 106():202-6. PubMed ID: 26282568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed carotid blow-out syndrome: a new complication of chemoradiotherapy treatment in pharyngolaryngeal carcinoma.
    Esteller E; León X; de Juan M; Quer M
    J Laryngol Otol; 2012 Nov; 126(11):1189-91. PubMed ID: 22963758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
    Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P
    Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
    Amr S; Ioffe D; Suzuki I; Mehra R; Cullen K; Goloubeva O
    Head Neck; 2021 Dec; 43(12):3935-3945. PubMed ID: 34632677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.